35
Metabolische Konsequenzen der Hämodialysetherapie Prof. Dr. Wilfred Druml Klinik für Innere Medizin III; Abteilung für Nephrologie und Hämodialyse Medizinische Universität Wien/Allgemeines Krankenhaus Wien, Österreich [email protected]

Metabolische Konsequenzen der Hämodialysetherapie · Metabolische Konsequenzen der Hämodialysetherapie. ... Increment in fibrinogen fractional synthetic rates ... and a test meal

Embed Size (px)

Citation preview

Page 1: Metabolische Konsequenzen der Hämodialysetherapie · Metabolische Konsequenzen der Hämodialysetherapie. ... Increment in fibrinogen fractional synthetic rates ... and a test meal

Metabolische Konsequenzen der Hämodialysetherapie

Prof. Dr. Wilfred DrumlKlinik für Innere Medizin III;

Abteilung für Nephrologie und HämodialyseMedizinische Universität Wien/Allgemeines Krankenhaus Wien,

Österreich

[email protected]

Page 2: Metabolische Konsequenzen der Hämodialysetherapie · Metabolische Konsequenzen der Hämodialysetherapie. ... Increment in fibrinogen fractional synthetic rates ... and a test meal

l Verlust von Nährstoffenl Verlust von Proteinen / Blutl Inflammation durch Bioinkompatibilitätl Inflammation durch intestinale Effektel Effekte durch Antikoagulation l gesteigerter Katabolismus l erhöhte ROS-Produktion

Beachte: diese Ursachen sind miteinander verflochten

Beteiligte Ursachen

Metabolische Konsequenzen der Hämodialysetherapie

Page 3: Metabolische Konsequenzen der Hämodialysetherapie · Metabolische Konsequenzen der Hämodialysetherapie. ... Increment in fibrinogen fractional synthetic rates ... and a test meal

Nährstoffverluste durch RRT

l Glukose / Wärme…l Aminosäuren (z.B. Glutamin)l Peptide l Albumin / Proteinl Wasserlösliche Vitamine l Spurenelemente ?? l Elektrolyte (Phosphat!!)l Carnitin l etc ....

Beachte : Diese Verluste müssen in der Ernährung des HD-

Patienten berücksichtigt werden!

Page 4: Metabolische Konsequenzen der Hämodialysetherapie · Metabolische Konsequenzen der Hämodialysetherapie. ... Increment in fibrinogen fractional synthetic rates ... and a test meal

Convective and diffusive losses of vitamin C during hemodiafiltration

session: a contributive factor to oxidative stress in HD patients

Morena M. et al. Nephrol Dial Transplant 2002; 17: 422-27

Dialytic losses of vitamin C (n=19). Blood samples were collected before and after HDF session

Page 5: Metabolische Konsequenzen der Hämodialysetherapie · Metabolische Konsequenzen der Hämodialysetherapie. ... Increment in fibrinogen fractional synthetic rates ... and a test meal

Convective and diffusive losses of vitamin C during hemodiafiltration session:

a contributive factor to oxidative stress in hemodialysis patients

Morena M. et al. Nephrol Dial Transplant 2002; 17: 422-27

Convective and diffusive losses of vit C during HDF session. At 60 min of HDF, vit C contents in AL, VL, D, and UF were assessed. A total loss of vit C could be assessed at 66 mg/session (8–230).

Page 6: Metabolische Konsequenzen der Hämodialysetherapie · Metabolische Konsequenzen der Hämodialysetherapie. ... Increment in fibrinogen fractional synthetic rates ... and a test meal

Serum concentrations and clearances of folic acid and pyridoxal-5-

phosphate during venovenous CRRTFortin MC et al. Intensive Care Med 1999; 25: 594-598

Daily removal of folic acid (in nmol/day) during CRRT as measured from the effluent side

Page 7: Metabolische Konsequenzen der Hämodialysetherapie · Metabolische Konsequenzen der Hämodialysetherapie. ... Increment in fibrinogen fractional synthetic rates ... and a test meal

Lactic Acidosis in Thiamine -Deficiency

Madl Christian et al. Clin Nutr 1993; 12: 67

Plasma lactate concentrations in two patients with thiamine deficiency before and after thiamine infusion

Page 8: Metabolische Konsequenzen der Hämodialysetherapie · Metabolische Konsequenzen der Hämodialysetherapie. ... Increment in fibrinogen fractional synthetic rates ... and a test meal

Antioxidant status in patients on chronic hemodialysis therapy: impact of parenteral

selenium supplementationKönig JS et al. Wien Klin Wochenschr 1997; 109: 13-19.

Selenium concentrations at blood inlet and outlet of the dialyzer capillary and in dialysate during hemodialysis in 7 patients

Page 9: Metabolische Konsequenzen der Hämodialysetherapie · Metabolische Konsequenzen der Hämodialysetherapie. ... Increment in fibrinogen fractional synthetic rates ... and a test meal

Severe acute hypophosphatemia during renal replacement therapy (IHD)

adversely affects outcome of critically ill patientswith acute kidney injury

Schiffl H. et al. Int Urol Nephrol 2013; 45: 191-97

Mean serum phosphate during IHD in critically patients without or with sodium phosphate supplementation (hospital and 1-

year mortality higher without supplementation 0.05)

Page 10: Metabolische Konsequenzen der Hämodialysetherapie · Metabolische Konsequenzen der Hämodialysetherapie. ... Increment in fibrinogen fractional synthetic rates ... and a test meal

Hemodialysis stimulates muscle and whole body protein loss and alters

substrate oxidationIkizler A et al. Am J Physiol 2002; 282: E107-16

Net forearm muscle protein loss comparing predialysis and dialysis periods for individual data points

Page 11: Metabolische Konsequenzen der Hämodialysetherapie · Metabolische Konsequenzen der Hämodialysetherapie. ... Increment in fibrinogen fractional synthetic rates ... and a test meal

Inflammatory signals associated with hemodialysis

Caglar Kaiser et al. Kidney int 2002; 62: 1408-16

Increment in fibrinogen fractional synthetic rates (FSR) during each study period * P< 0.05 vs. baseline

Page 12: Metabolische Konsequenzen der Hämodialysetherapie · Metabolische Konsequenzen der Hämodialysetherapie. ... Increment in fibrinogen fractional synthetic rates ... and a test meal

Inflammatory signals associated with hemodialysis

Caglar Kaiser et al. Kidney int 2002; 62: 1408-16

Increment in IL-6 concentration during each study period for each individual patient. The mean depicted in bold.

*significant from baseline period (P < 0.05); denotes P = 0.05 vs. hemodialysis for mean

Page 13: Metabolische Konsequenzen der Hämodialysetherapie · Metabolische Konsequenzen der Hämodialysetherapie. ... Increment in fibrinogen fractional synthetic rates ... and a test meal

Skeletal muscle, cytokines, and oxidative stress in end-stage renal

diseaseRaj DS et al. Kidney int 2005; 68: 2338-43

Interleukin-6 (IL-6) and hemeoxygenase-1 (HO-1) and suppressors of cytokine signaling-2 (SOCS-2) gene expression in skeletal muscle (!) were increased during hemodialysis (HD)

Page 14: Metabolische Konsequenzen der Hämodialysetherapie · Metabolische Konsequenzen der Hämodialysetherapie. ... Increment in fibrinogen fractional synthetic rates ... and a test meal

Activity of glutathione peroxidase in CO, CRF and HD patients

Mimic-Oka J. et al. Clin. Nephrol. 51:233-241, 1999G

luta

thio

ne p

erox

idas

e (U

/L p

lasm

a)

> 90 51-90 21-50 < 20 HDCreatinine clearance (ml/min)

0

100

200

300

400

*****

*** ***, a

** p < 0.01*** p < 0.001

a p < 0.05

Page 15: Metabolische Konsequenzen der Hämodialysetherapie · Metabolische Konsequenzen der Hämodialysetherapie. ... Increment in fibrinogen fractional synthetic rates ... and a test meal

Effect of a single hemodialysis session on inflammatory markers

Bitla AR et al. Hemodial Int 2010; 14: 411-17

Time course of changes observed in LpPLA2 activity. Data were corrected for hemoconcentration with albumin converted to percentages (predialytic value =100%). LpPLA2 lipoprotein

associated phospholipase A2

Page 16: Metabolische Konsequenzen der Hämodialysetherapie · Metabolische Konsequenzen der Hämodialysetherapie. ... Increment in fibrinogen fractional synthetic rates ... and a test meal

CVVH in PolytraumaMarzi I et al. Homburg/ Saar 1994

C-reactive protein in control group (o) and CVVH group

Page 17: Metabolische Konsequenzen der Hämodialysetherapie · Metabolische Konsequenzen der Hämodialysetherapie. ... Increment in fibrinogen fractional synthetic rates ... and a test meal

Splanchnic perfusion during hemodialysis: Evidence for marginal

tissue perfusionJakob SM et al. Crit Care Med 2001; 29: 1393-98

Fractional splanchnic blood flow before, during, after hemodialysis. The 20%, 30%, and 40% lines = proportion of splanchnic blood flow of cardiac index and fractional femoral blood flow before, during, and after hemodialysis. The 4%, 8%, and 12% lines =

proportion of femoral blood flow of cardiac index

Page 18: Metabolische Konsequenzen der Hämodialysetherapie · Metabolische Konsequenzen der Hämodialysetherapie. ... Increment in fibrinogen fractional synthetic rates ... and a test meal

Mucosal Biofilm in Congestive Heart Failure

Highly colonised large intestinal mucosa

Low colonisedlarge intestinal mucosa

Controls Chronic heart failure

Bauditz & Swidsinski et al., DDW 2006, Poster # M1168

Page 19: Metabolische Konsequenzen der Hämodialysetherapie · Metabolische Konsequenzen der Hämodialysetherapie. ... Increment in fibrinogen fractional synthetic rates ... and a test meal

Circulating Endotoxemia: A Novel Factor in Systemic Inflammation and Cardiovascular

Disease in Chronic Kidney DiseaseMcIntyre CW et al. Clin-JASN 2011;6:133-41

(a) Distribution of circulating endotoxin levels across the spectrum of CKD patients at baseline. Pediatric HD patients are

illustrated separately (OE). (b) Association of estimated GFR and circulating endotoxin levels in nondialysis-dependent CKD patients

Page 20: Metabolische Konsequenzen der Hämodialysetherapie · Metabolische Konsequenzen der Hämodialysetherapie. ... Increment in fibrinogen fractional synthetic rates ... and a test meal

Associations between renal function, volume status and endotoxaemia in

chronic kidney disease patientsGoncalves S et al. NDT 2006; 21: 2788-94

Correlation between endotoxin levels and fluid status in patients with CKD 3 - 4 (GFR 34 ml/min).

*Fluid overload defined as inferior vena cava diameter of >11.5mm/m2 **defined as collapsing index <40%

Page 21: Metabolische Konsequenzen der Hämodialysetherapie · Metabolische Konsequenzen der Hämodialysetherapie. ... Increment in fibrinogen fractional synthetic rates ... and a test meal

Sandek A. et al. J Am Coll Cardiol 2007; 50: 1561-6

Bowel wall thickness (transcutaneous abdominal sonography) of terminal ileum, ascending colon, transverse colon, descending colon and sigmoid in

chronic heart failure (CHF) patients compared with control subjects. Measurement of bowel wall thickness in a healthy control subject (B) and a

patient with CHF (C)

Altered intestinal function in patients with chronic heart failure

Page 22: Metabolische Konsequenzen der Hämodialysetherapie · Metabolische Konsequenzen der Hämodialysetherapie. ... Increment in fibrinogen fractional synthetic rates ... and a test meal

The mortality risk of overhydration in haemodialysis patients

Wizemann V et al. NDT 2009; 24: 1574-79

Kaplan–Meier curve separating the patients for the relative hydration status (ΔHS >15%)

Page 23: Metabolische Konsequenzen der Hämodialysetherapie · Metabolische Konsequenzen der Hämodialysetherapie. ... Increment in fibrinogen fractional synthetic rates ... and a test meal

High dietary fiber intake is associated with decreased inflammation and all-

cause mortality in patients with chronic kidney disease

Krishnamurthy VM. et al. Kidney int 2012; 81: 300-06

Associations of dietary fiber with elevated serum C-reactive protein(>3mg/l) in the non-chronic kidney disease (CKD) and CKD sub-populations. Model adjusted for many confounders

Page 24: Metabolische Konsequenzen der Hämodialysetherapie · Metabolische Konsequenzen der Hämodialysetherapie. ... Increment in fibrinogen fractional synthetic rates ... and a test meal

IL-1ß Receptor Antagonist Reduces Inflammation in Hemodialysis Patients

Hung AM et al. JASN 2011; 22: 437-42

Pre- and poststudy levels of hsCRP (mg/dl) and IL-6 (pg/ml). hsCRP decreased in all but one individual in with IL-1ra

(Anakinra), all placebo subjects were either stable or increased their hsCRP. A similar trend was observed for IL-6 levels

Page 25: Metabolische Konsequenzen der Hämodialysetherapie · Metabolische Konsequenzen der Hämodialysetherapie. ... Increment in fibrinogen fractional synthetic rates ... and a test meal

l Dialysatl Shuntl Katheter !l „Oral health“l Volumenüberladung (Darm) l repetitive intestinale Ischämiel ?

Beachte : Eine (chronische) Endotoxinämie ist eine wichtige Ursach der Inflammation bei HD Patienten

The Dark Side of Hemodialysis

Ursachen der Endotoxinämie

Page 26: Metabolische Konsequenzen der Hämodialysetherapie · Metabolische Konsequenzen der Hämodialysetherapie. ... Increment in fibrinogen fractional synthetic rates ... and a test meal

l Bioinkompatibilität von künstlichen Membranenl Bioinkompatibilität vom Schlauchsystem/

Luft-Blut Interaktion l Inadäquate Dialysedosis (Urämie als Inflammation)l Endotoxinämie l Katheter-/ Shunt-Infektionenl Verlust von antioxidativen Faktoren l Interkurrente Infektionenl Eisentherapiel Antikoagulation (Heparin !)l etc.

InflammationDialyse-assoziierte Ursachen

Page 27: Metabolische Konsequenzen der Hämodialysetherapie · Metabolische Konsequenzen der Hämodialysetherapie. ... Increment in fibrinogen fractional synthetic rates ... and a test meal

Hemodialysis stimulates muscle and whole body protein loss and alters

substrate oxidationIkizler AP et al. Am J Physiol 2002; 282: E107-E116

Whole body protein metabolism. FFM, fat-free mass. *Significant difference from basal period (P < 0.05); §significant difference

between dialysis and postdialysis periods (P < 0.05)

Page 28: Metabolische Konsequenzen der Hämodialysetherapie · Metabolische Konsequenzen der Hämodialysetherapie. ... Increment in fibrinogen fractional synthetic rates ... and a test meal

Protein intake during hemodialysis maintains a positive whole body protein balance in chronic hemodialysis patients

Veeneman JM. et al. Am J Physiol 2003; 284: E954

Whole body protein breakdown (gray bars), synthesis (open bars), and protein balance (filled bars) during HD and fasting (fas) and a test meal (fed)HD- between HD HD+ during HD

Page 29: Metabolische Konsequenzen der Hämodialysetherapie · Metabolische Konsequenzen der Hämodialysetherapie. ... Increment in fibrinogen fractional synthetic rates ... and a test meal

Intradialytic Oral Nutrition Improves Protein Homeostasis in Chronic

Hemodialysis Patients with Deranged Nutritional Status

Pupim L et al JASN 2006; 17: 3149-57

Whole body (WB) protein homeostasis during HD, comparing control, IDPN and PO. * p< 0.05 vs. Control, § p < 0.05 vs IDPN

Page 30: Metabolische Konsequenzen der Hämodialysetherapie · Metabolische Konsequenzen der Hämodialysetherapie. ... Increment in fibrinogen fractional synthetic rates ... and a test meal

Antikoagulation bei RRT

Heparinl AT-III - Verbrauchl Zell-Aktivierung (Thrombocyten, Granulocyten)l Heparin-induzierte Thrombopenie I + IIl ROS Bildungl pro-inflammatorische Effekte l metabolische Nebenwirkungen (Lipolyse)l Allergische Reaktionenl (Osteoporose)l (Alopezie)

Heparin – nicht-antikoagulatorische Effekte

LMWH haben etwas weniger ausgeprägte Effekte..….

Page 31: Metabolische Konsequenzen der Hämodialysetherapie · Metabolische Konsequenzen der Hämodialysetherapie. ... Increment in fibrinogen fractional synthetic rates ... and a test meal

Antikoagulation bei CRRTHeparin and Inflammation

Heparins bind to proteins and cells, and thereby interfere with the inflammatory cascade and, altogether, confer unpredictable consequences for critically ill patients. H, heparin; AT, antithrombin; LBP, lipopolysaccharide-binding protein; M, monocyte; MPO, myeloperoxidase; SOD, superoxide dismutase; GAGs, glucosaminoglycans; P, platelet; L, leukocyte

from Oudemans-van Straaten H, Crit Care 2011; 15: 202

Page 32: Metabolische Konsequenzen der Hämodialysetherapie · Metabolische Konsequenzen der Hämodialysetherapie. ... Increment in fibrinogen fractional synthetic rates ... and a test meal

Platelet activation in clinical haemodialysis: LMWH as a major

contributor to bio-incompatibility?Gritters M et al. Nephrol Dia Transplant 2008; 23: 2911-17

Platelet factor 4 (PF4) (IU/ml) during HD (t0, t5, t30, t60 and t150) at 3 sampling points in the ECC, (1) afferent line (before roller pump), (2) first deflation chamber (between roller pump and dialyser), (3) efferent line (after the dialyser)°P = 0.005 vs baseline

Page 33: Metabolische Konsequenzen der Hämodialysetherapie · Metabolische Konsequenzen der Hämodialysetherapie. ... Increment in fibrinogen fractional synthetic rates ... and a test meal

Reduction of granulocyte activation during hemodialysis with regional citrateanticoagulation: dissociation ofcomplement activation and neutropenia from neutrophil degranulation

Böhler Joachim et al.J Am Soc Nephrol 1996; 7: 234-41

Page 34: Metabolische Konsequenzen der Hämodialysetherapie · Metabolische Konsequenzen der Hämodialysetherapie. ... Increment in fibrinogen fractional synthetic rates ... and a test meal

Effect of Hemodialysis Before Transplant Surgery on Renal

Allograft Function—A Pair of RCTsKikic et al. Transplantation 2009;88:1372-85

Effect of pretransplant dialysis mode on glomerular filtration rate. (B) Comparison of preoperative dialysis with systemic heparin anticoagulation

(open plots) versus dialysis with citrate anticoagulation (hatched plots).

A

A

S

A

A

A

S

S

SS

S

AAA

AA

S

SSS

A

A

A

A

AA

A

A AA

25

50

75

100

125eG

FR (

ml/m

in)

Days after transplantation

0.8 0.9 0.9 0.6 0.5 0.3 0.1P=0.3

1 2 3 4 5 6 7 30 365

0.0336 vs. 47 ml/min, p < 0.03

Page 35: Metabolische Konsequenzen der Hämodialysetherapie · Metabolische Konsequenzen der Hämodialysetherapie. ... Increment in fibrinogen fractional synthetic rates ... and a test meal

Danke für Ihre Aufmerksamkeit

Prof. Dr. Wilfred DrumlKlinik für Innere Medizin III;

Abteilung für Nephrologie und HämodialyseMedizinische Universität Wien/Allgemeines Krankenhaus Wien,

Österreich

[email protected]